News

Since day one, dQ&A has elevated diabetes patient voices—explore our infographic to see how these insights have shaped client decisions over the years.

Our research reveals low awareness of DKA and ketone testing among type 2 diabetes patients on SGLT2 inhibitors, highlighting urgent education needs.

Erik Shoger presented real-world patient insights at the FDA advisory meeting on sotagliflozin, highlighting the need for education and training if approved.

We invite you to watch this 4-minute selfie video reel featuring real people describing their very real struggles with diabetes.

Our quarterly U.S. diabetes survey found one-third of respondents had mild or severe depression, underscoring the need for more support and better treatments.

Our research found that social stigma perceptions were more common in type 1 diabetes than type 2, possibly because type 2 is less visible.